RT Journal Article
SR Electronic
T1 High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 351
DO 10.1186/s40425-019-0827-2
VO 7
IS 1
A1 Massarelli, Erminia
A1 Lam, Vincent K.
A1 Parra, Edwin R.
A1 Rodriguez-Canales, Jaime
A1 Behrens, Carmen
A1 Diao, Lixia
A1 Wang, Jing
A1 Blando, Jorge
A1 Byers, Lauren A.
A1 Yanamandra, Niranjan
A1 Brett, Sara
A1 Morley, Peter
A1 Sharma, Padmanee
A1 Allison, James
A1 Wistuba, Ignacio I.
A1 Heymach, John V.
YR 2019
UL http://jitc.bmj.com/content/7/1/351.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.